Attached files
| file | filename |
|---|---|
| 10-Q - SEPT 2009 10 Q - ANTARES PHARMA, INC. | thirdqtr10q.htm |
| EX-31.2 - ANTARES PHARMA, INC. | ex31-2.htm |
| EX-32.2 - ANTARES PHARMA, INC. | ex32-2.htm |
| EX-31.1 - ANTARES PHARMA, INC. | ex31-1.htm |
Exhibit 32.1
ANTARES
PHARMA, INC.
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT
TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)
The
undersigned, Dr. Paul K. Wotton, the Chief Executive Officer of Antares Pharma,
Inc. (the “Company”), has executed this Certification in connection with the
filing with the Securities and Exchange Commission of the Company’s Quarterly
Report on Form 10-Q for the fiscal quarter ended September 30, 2009 (the
“Report”).
The
undersigned hereby certifies that:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934, as amended;
and
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
IN
WITNESS WHEREOF, the undersigned has executed this Certification as of the 12th
day of November, 2009.
|
/s/
Paul K. Wotton
|
||||
|
Dr.
Paul K. Wotton
President
and Chief Executive Officer
|
||||